SUBSCRIBE NEWSLETTER
  • Change Language
  • English
  • Hindi
  • Marathi
  • Gujarati
  • Punjabi
  • Tamil
  • Telugu
  • Bengali
  • Insurance Religare to exit joint venture with Aegon

    Religare to exit joint venture with Aegon

    The decision was taken after a strategic review of the business.
    Team Cafemutual Sep 26, 2014

    The decision was taken after a strategic review of the business.

    Religare Enterprises has decided to exit its joint venture with Aegon in its life insurance business. The decision came after a strategic review of the company.

    Currently, Religare holds 44% equity in Aegon Religare Life Insurance. Started in 2008, Aegon Religare Life Insurance started is a joint venture between Aegon, Religare and Bennett, Coleman and Company.

    Religare Enterprise has announced its desire to exit the joint venture through an announcement on Bombay Stock Exchange (BSE). Both companies Religare and Aegon have agreed that Religare will exit once a replacement shareholder authority is identified and approved by IRDA. In the meantime, Religare remains fully committed to the joint venture, said the company.

    A senior official of Aegon Religare Life Insurance confirmed this development to Cafemutual.

    A few days back, IRDA had imposed a fine of Rs.40 lakh on Aegon Religare Life Insurance for violation of various distribution norms like soliciting business with unauthorized agents, luring employees of broking firms with gifts/rewards, making additional payouts to its corporate agents for advertisement and sharing data base of prospects with its group company called Religare Macquarie Wealth Management.

    Aegon Religare incurred loss a loss of Rs.13 crore in the first quarter of current financial year. The company posted a loss of Rs.15 crore in FY 13-14 and Rs.17 crore in FY 2012-13.

    In 2011, Aegon exited its joint venture with Religare in the asset management business which was later took over by Invesco.


    wives who cheat on husbands wife cheated
    link click here website
    what is medical abortion abortion support mifeprex abortion pill
    Have a query or a doubt?
    Need a clarification or more information on an issue?
    Cafemutual welcomes all mutual fund and insurance related questions. So write in to us at newsdesk@cafemutual.com

    Click to clap
    Disclaimer: Cafemutual is an industry platform of mutual fund professionals. Our visitors are requested to maintain the decorum of the platform when expressing their thoughts and commenting on articles. Viewers are advised to refrain from making defamatory allegations against individuals. Those making abusive language or defamatory allegations will be blocked from accessing the web site.
    0 Comment
    Be the first to comment.
    Login or Sign up to post comments.
    More than 2,07,000 of your industry peers are staying on top of their game by receiving daily tips, ideas and articles on growth strategies. Join them and stay updated by subscribing to Cafemutual newsletters.

    Fill in the below details or write to newsdesk@cafemutual.com and subscribe to Cafemutual Newsletter now.
    Cafemutual is an independent media platform and focuses on providing knowledge and information for the benefit of finance professionals. We do not promote any particular brand or asset category.